Exploring limitations in the current standard of care for thyroid hormone replacement therapy in thyroid cancer survivors

Summary

We are asking thyroid cancer survivors who are currently undergoing treatment for their post-thyroidectomy care to answer a short survey about their care experiences, some related symptom management, and a few questions about how they work with their doctors.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 111

Accepts healthy participants: Yes

Inclusion criteria:

- 18 years or older
- partial or total removal of thyroid gland (thyroidectomy) for the treatment of thyroid cancer
- now require treatment with any kind of thyroid hormone replacement medication (e.g., Synthroid, desiccated thyroid extract, liothyronine, levothyroxine, or any combination therapy)

Exclusion criteria:

- Less than 18 years old
- Anyone who has not had some or all of their thyroid gland removed
- Not on any thyroid medication (e.g., Synthroid, desiccated thyroid extract, liothyronine, levothyroxine, or any combination therapy)

Participate

Fill out the following form if you want to participate in this research

Method of contact

Additional information

Contact information

Email julie.babione@ucalgary.ca or leave a message at 403-210-7389 for more information.

Principal investigator:

Sana Ghaznavi

Clinical trial:

No

REB-ID:

HREBA.CC-23-0125